- Home
- ACLS vs CRNX Comparison
ACLS vs CRNX Comparison
Compare ACLS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- CRNX
- Stock Information
- Founded
- ACLS 1995
- CRNX 2008
- Country
- ACLS United States
- CRNX United States
- Employees
- ACLS N/A
- CRNX N/A
- Industry
- ACLS Industrial Machinery/Components
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- CRNX Health Care
- Exchange
- ACLS Nasdaq
- CRNX Nasdaq
- Market Cap
- ACLS 2.3B
- CRNX 2.8B
- IPO Year
- ACLS 2000
- CRNX 2018
- Fundamental
- Price
- ACLS $75.51
- CRNX $31.75
- Analyst Decision
- ACLS Buy
- CRNX Strong Buy
- Analyst Count
- ACLS 7
- CRNX 8
- Target Price
- ACLS $138.00
- CRNX $74.86
- AVG Volume (30 Days)
- ACLS 522.2K
- CRNX 751.6K
- Earning Date
- ACLS 07-30-2025
- CRNX 08-07-2025
- Dividend Yield
- ACLS N/A
- CRNX N/A
- EPS Growth
- ACLS N/A
- CRNX N/A
- EPS
- ACLS 5.46
- CRNX N/A
- Revenue
- ACLS $958,056,000.00
- CRNX $760,000.00
- Revenue This Year
- ACLS N/A
- CRNX $402.02
- Revenue Next Year
- ACLS $7.62
- CRNX $771.03
- P/E Ratio
- ACLS $13.70
- CRNX N/A
- Revenue Growth
- ACLS N/A
- CRNX N/A
- 52 Week Low
- ACLS $40.40
- CRNX $24.10
- 52 Week High
- ACLS $158.00
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- ACLS 68.26
- CRNX 57.94
- Support Level
- ACLS $70.64
- CRNX $28.98
- Resistance Level
- ACLS $76.80
- CRNX $32.49
- Average True Range (ATR)
- ACLS 2.41
- CRNX 1.24
- MACD
- ACLS 0.18
- CRNX 0.30
- Stochastic Oscillator
- ACLS 90.42
- CRNX 90.54
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.